Warning: The NCBI web site requires JavaScript to function. more...
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Bao T, Davidson NE.
Breast Cancer Res. 2007;9(6):115.
Related citations
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Goel S, Sharma R, Hamilton A, Beith J.
Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. Review.
Adjuvant endocrine treatment of early breast cancer.
Lønning PE.
Hematol Oncol Clin North Am. 2007 Apr;21(2):223-38. Review.
Optimal adjuvant endocrine therapy for early breast cancer.
Stuart-Harris R, Davis A.
Womens Health (Lond Engl). 2010 May;6(3):383-98. Review.
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.
Pritchard KI.
Oncology (Williston Park). 2009 Jan;23(1):27-33. Review.
Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
Michaud LB, Buzdar AU.
Drugs Aging. 2000 Apr;16(4):261-71. Review.
Adjuvant endocrine therapy for premenopausal women with breast cancer.
Puhalla S, Brufsky A, Davidson N.
Breast. 2009 Oct;18 Suppl 3:S122-30. Review.
Selecting adjuvant endocrine therapy for breast cancer.
Eneman JD, Wood ME, Muss HB.
Oncology (Williston Park). 2004 Dec;18(14):1733-44, discussion 1744-5, 1748, 1751-4. Review.
Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.
Al-Hajj A, O'Regan R.
Curr Treat Options Oncol. 2006 Mar;7(2):153-65. Review.
Sharma R, Hamilton A, Beith J.
Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.
[Adjuvant treatment of breast cancer. Endocrine therapy].
Mouridsen HT, Andersen J.
Ugeskr Laeger. 2007 Sep 10;169(37):3072-6. Danish.
Dellapasqua S, Colleoni M, Gelber RD, Goldhirsch A.
J Clin Oncol. 2005 Mar 10;23(8):1736-50. Review. No abstract available.
Endocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal women.
Pritchard K.
Breast Cancer Res. 2005;7(2):70-6. Epub 2005 Feb 11. Review.
[Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
Mauriac L, Blanc-Vincent MP, Luporsi E, Cutuli B, Fourquet A, Garbay JR, Giard S, Spyratos F, Zafrani B, Dilhuydy JM.
Bull Cancer. 2000 Jun;87(6):469-90. Review. French.
Adjuvant hormonal therapy for premenopausal women with breast cancer.
Emens LA, Davidson NE.
Clin Cancer Res. 2003 Jan;9(1 Pt 2):486S-94S.
Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS, El-Hajj II, Makarem JA, Otrock ZK.
Anticancer Drugs. 2006 Sep;17(8):999-1002.
Controversies in adjuvant endocrine treatment of premenopausal women.
Goldstein LJ.
Clin Breast Cancer. 2006 Feb;6 Suppl 2:S36-40. Review.
Adjuvant endocrine therapy in premenopausal women with breast cancer.
González Martín A, de la Cruz S, Márquez R.
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. Epub 2010 Aug 14. No abstract available.
Ovarian ablation for premenopausal early-stage breast cancer: an update.
Celio L, Bajetta E, Toffolatti L, Catena L, Beretta E, Buzzoni R.
Tumori. 2000 May-Jun;86(3):191-4. Review.
Role of adjuvant endocrine therapy in early-stage breast cancer.
Muss HB.
Semin Oncol. 2001 Aug;28(4):313-21. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on